ArticleJournal of virology2026
West Nile virus and Zika virus infections induce aggresome formation in human neural progenitor and A549 cells.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Zika virus and host innate immunity: mechanisms of activation and evasion.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Zika viral replication vesicles (VRVs) were previously observed to cluster asymmetrically on one side of the nucleus in infected Huh7, A549, and h-NPCs. West Nile virus (WNV) infections in these cells also induce asymmetrically clustered VRVs. The sequential cell responses leading to asymmetric clustering of the WNV and ZIKV VRVs were investigated. Both infections activated the cellular unfolded protein response (UPR), as indicated by increased expression of GRP78, the master regulator of UPR, and activation of the PERK branch of the UPR (p-PERK-p-eIF2α-GADD34). Increased microtubule (MT) acetylation was also induced. As the infection progressed, the level of ubiquitinated proteins increased and GRP78, ubiquitinated proteins, the deacetylase HDAC6, VRVs, and modified endoplasmic reticulum clustered at the cellular microtubule-organizing center (MTOC) and became surrounded by a vimentin "cage." The components involved in the formation of asymmetric VRVs are characteristic of aggresome formation, an additional cellular response that copes with excessive misfolded proteins when the UPR is overwhelmed. During aggresome formation, HDAC6 links polyubiquitinated proteins to the dynein motor complex for transport along MTs to the MTOC, where they aggregate and are surrounded by a vimentin cage. HDAC6 knockdown prevented asymmetric clustering of viral replication complexes, resulted in activation of the p-PERK-p-eIF2α-CHOP apoptotic pathway, and decreased viral yield. The threshold for triggering aggresome formation varied with the infecting orthoflavivirus and cell type. The formation of aggresome-like, asymmetric VRVs in A549 cells and h-NPCs infected with WNV or ZIKV delayed activation of the cellular death pathways and increased viral yield. IMPORTANCE: Zika virus and West Nile virus replication complexes, which are typically symmetrically distributed around the nucleus in the perinuclear region of an infected cell, cluster asymmetrically on one side of the nucleus in A549 and human neural progenitor cells as the infections progress. Analysis of the sequential cellular responses involved showed that microtubule acetylation increased and the unfolded protein response was activated; then, the levels of ubiquitinated protein and HDAC6 increased, followed by asymmetric concentration of the viral replication complexes, ubiquitinated proteins, and HDAC6 at the cellular microtubule-organizing center, where they became surrounded by a vimentin cage. These sequential steps are characteristic of aggresome formation, an additional protective cellular response that copes with the accumulation of toxic misfolded proteins. This response delayed activation of cell death pathways and extended virus production. Both cell type-specific and orthoflavivirus-specific characteristics determine whether a particular infection induces aggresome formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.